That Time Snoop Dogg Ate Mushrooms and Cried Backstage
“I don’t even know what got into my emotions, but I felt so good, and the crying just made me feel even better,” the Super Bowl halftime show performer says.
Greg Gilman is Psychedelic Spotlight's lead content editor, as well as a contributor. His previous work has appeared in dozens of publications, including USA Today, Yahoo! News, TheWrap, MovieMaker Magazine and SyFy Wire. When he's not writing, he's the lead singer for LA-based Americana rock band Greg in Good Company. Given his experience as an artist, he's particularly interested in the intersection of psychedelics and entertainment.
“I don’t even know what got into my emotions, but I felt so good, and the crying just made me feel even better,” the Super Bowl halftime show performer says.
Levitee Labs Announces Interim CEO and Board of Directors Shuffle This week in psychedelic business news, Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7), a psychedelic medicine and wellness company, has appointed Philip van den Berg as Chief Executive Officer and to the Board of Directors, replacing Pouya Farmand, who will be moving to […]
This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one of the biggest gets bigger.
Difficult trips could be a problem in areas where psychedelics have been decriminalized, which is why MAPS will offer a psychonaut training program.
Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
Agency argues these five tryptamines “have no known medical use,” setting up a showdown with the emerging psychedelics industry.
Americans continue to open their minds to ketamine, psilocybin, and MDMA treatment for depression, anxiety, and PTSD.
Tim Ferriss and Roland Griffiths are among the biggest names in the burgeoning psychedelics movement that are set to appear during the SXSW Conference running from March 11-20.
It’s yet another sign that the pharmaceutical industry at large is taking the potential of psychedelics very seriously.
New amendment reverses a 2013 Health Canada policy that prevented “a letter of authorization for a new drug that is or that contains a restricted drug.”
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.